PYC pyc therapeutics limited

masquerade or charade?, page-7

  1. 315 Posts.
    Andrewk65, do you seriously believe that Janssen would maneuver to:

    - Promote a Phylogica capital raising by implying a deal was in the offing;

    - String along the development, once the capital was in place; with the implication that:

    - They will dump the project once the development has achieved milestones.

    I have no doubt that Janssen is a serious partner and that their goals and objectives are more clearly understood by applying commercial logic:

    - The EET is their delivery technology for an undisclosed payload;

    - We do not know if the payload is a Phylomer or if it is a Janssen development - however, it does not really matter because the delivery technology is the really valuable thing (and currently, Phylogical owns this).

    Valuing Phylogica depends on a deep understanding of the value of their technologies. Price action on the stock exchange is not a factor in the objective assesment of this technology.

    The traders got on board to drive the price from about 1.5c to 3.8c. The traders took their profits. I see nothing fundamental in this little side show.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.42
Change
-0.025(1.73%)
Mkt cap ! $850.1M
Open High Low Value Volume
$1.44 $1.47 $1.40 $364.7K 251.9K

Buyers (Bids)

No. Vol. Price($)
6 7552 $1.42
 

Sellers (Offers)

Price($) Vol. No.
$1.44 1414 1
View Market Depth
Last trade - 15.20pm 10/07/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.